The PI3K-AKT-mTOR pathway serves as the metabolic-proliferative hub in ovarian cancer, driving tumorigenesis by orchestrating cell survival, cell cycle progression, and DNA repair. Here, PIK3CA is linked to ovarian carcinoma.